Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

After J&J-Synthes Deal, Will Orthopedic Consolidation Hit Zimmer, Stryker?

This article was originally published in The Gray Sheet

Executive Summary

In the wake of Johnson & Johnson’s $21.3 billion purchase of orthopedic implant maker Synthes, other large ortho firms like Zimmer and Stryker may face growing pressure to make their own acquisitions in order to stay competitive, market watchers speculate.

You may also be interested in...



Stryker Bets $316 Million It Can Invigorate Orthovita's Biologics Biz

Stryker hopes its sales force heft can push Orthovita's line of synthetic orthobiologics into a better growth position while filling important competitive gaps.

Stryker Bets $316 Million It Can Invigorate Orthovita's Biologics Biz

Stryker hopes its sales force heft can push Orthovita's line of synthetic orthobiologics into a better growth position while filling important competitive gaps.

J&J Doubles Down On Orthopedics With Synthes Deal; Takes Lead In Trauma

Johnson & Johnson will control a majority of the orthopedic trauma device market and double its stake in the spinal device field by acquiring Synthes for $21.3 billion under a definitive agreement announced April 27.

Latest News
See All
UsernamePublicRestriction

Register

MT030079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel